CD276 (B7 Homolog 3, B7-H3) is a recently described immune checkpoint molecule, that suppresses T cell activation and proliferation, and is overexpressed in a variety of malignancies including MTC [82]. The gene discussed is CD276; the disease is medullary thyroid gland carcinoma.